# OnCo record neu-001 (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/neu-001/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "neu-001" ;
  schema:name "N17350"@en ;
  schema:alternateName "NEU-001"@en ;
  schema:description "N17350 is an experimental enzyme therapy: elastase injected into the tumour from Onchilles Pharma, in phase 1 trials for advanced solid tumours, triple-negative breast cancer and cutaneous squamous cell carcinoma and other cancers."@en ;
  schema:url <https://onco.cc/drugs/neu-001/> ;
  schema:dateModified "2026-11-03"^^xsd:date ;
  schema:citation <https://www.onchillespharma.com/>, <https://www.onchillespharma.com/>, <https://www.onchillespharma.com/>, <https://clinicaltrials.gov/api/v2/studies/NCT07339176>, <https://clinicaltrials.gov/search?intr=NEU-001> ;
  onco:status "phase-1" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:modality "Enzyme therapy: elastase injected into the tumour" ;
  onco:cancers <https://onco.cc/cancers/metastatic-cancer/>, <https://onco.cc/cancers/cutaneous-scc/>, <https://onco.cc/cancers/melanoma/>, <https://onco.cc/cancers/head-and-neck/>, <https://onco.cc/cancers/nsclc/> ;
  onco:companies <https://onco.cc/companies/onchilles-pharma/> ;
  onco:trials <https://onco.cc/trials/nct07339176/> .